Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older who have been diagnosed with prostate cancer (confirmed by biopsy) or are suspected of having prostate cancer, and who need and are willing to undergo a diagnostic procedure, treatment, or follow-up monitoring as part of their care
- People who are reasonably active and able to carry out daily activities (this is measured using a standard health scale called ECOG, with scores ranging from 0 to 2)
- People who are willing and able to give their informed consent to participate
- People aged 30 to 49 with a PSA blood test result of 1.0 ng/ml or higher (PSA is a protein measured in the blood that can indicate prostate issues)
- People aged 50 or older with a PSA blood test result of 2.5 ng/ml or higher
- People who have had an abnormal prostate examination by a doctor (for example, the prostate felt enlarged, uneven, lumpy, hard, or tender)
- People who have had an abnormal finding on a prostate MRI scan
- People with a close family history of prostate cancer in a father or brother, or a history of breast or ovarian cancer in a mother or sister
Who may not be able to join:
- People whose other health conditions would make it unsafe or impossible for them to undergo a diagnostic procedure or treatment (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Peter A Pinto, M.D., National Cancer Institute (NCI)
Phone: (240) 974-9026
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Collect samples for the purpose of studying the molecular mechanisms of carcinogenesis in prostate cancer
Can't join this trial?
Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.